Vicinitas Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Vicinitas Therapeutics's estimated annual revenue is currently $3.7M per year.
- Vicinitas Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Vicinitas Therapeutics has 48 Employees.
- Vicinitas Therapeutics grew their employee count by 55% last year.
Vicinitas Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP, Chemical Biology | Reveal Email/Phone |
4 | VP Human Resources | Reveal Email/Phone |
5 | VP Biology | Reveal Email/Phone |
6 | Director Protein Sciences | Reveal Email/Phone |
7 | Scientist II | Reveal Email/Phone |
8 | Senior Research Scientist | Reveal Email/Phone |
Vicinitas Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Vicinitas Therapeutics?
Many diseases, including cancer and monogenic diseases, are often caused by specific proteins that are abnormally degraded and lost from the cell. In cancer, protective tumor suppressors are aberrantly destroyed, allowing cancer cells to circumvent cell death, thus promoting unobstructed cell proliferation. To date, many aberrantly degraded proteins have been considered “undruggable” or intractable to drug discovery efforts. Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers known as Deubiquitinase Targeting Chimeras (DUBTACs). The company’s mission is to use this proprietary technology to solve critical problems in human health by developing next-generation disease therapies against an entire class of previously inaccessible disease-causing proteins. Spun out of an academic-industry collaboration between Novartis Institutes for BioMedical Research and the University of California, Berkeley, Vicinitas Therapeutics is based in South San Francisco, California.
keywords:N/AN/A
Total Funding
48
Number of Employees
$3.7M
Revenue (est)
55%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.6M | 48 | 37% | N/A |
#2 | $5.1M | 48 | -11% | $2.5M |
#3 | $5.4M | 48 | 0% | N/A |
#4 | $5.1M | 48 | -14% | $398.3M |
#5 | $4.7M | 48 | 41% | $43.7M |